Published in Oncogene on September 26, 2011
Protein kinase C, an elusive therapeutic target? Nat Rev Drug Discov (2012) 2.33
Protein kinase C and cancer: what we know and what we do not. Oncogene (2013) 1.09
Activation of nuclear factor κB (NF-κB) in prostate cancer is mediated by protein kinase C epsilon (PKCepsilon). J Biol Chem (2012) 0.88
Development of small RNA delivery systems for lung cancer therapy. Int J Mol Sci (2015) 0.85
siRNA delivery to the lung: what's new? Adv Drug Deliv Rev (2014) 0.83
Protein kinase Cα mediates erlotinib resistance in lung cancer cells. Mol Pharmacol (2015) 0.82
Transcriptional regulation of oncogenic protein kinase Cϵ (PKCϵ) by STAT1 and Sp1 proteins. J Biol Chem (2014) 0.81
Diacylglycerol kinase δ modulates Akt phosphorylation through pleckstrin homology domain leucine-rich repeat protein phosphatase 2 (PHLPP2). J Biol Chem (2012) 0.80
Regulation of Transcriptional Networks by PKC Isozymes: Identification of c-Rel as a Key Transcription Factor for PKC-Regulated Genes. PLoS One (2013) 0.79
Inflammation-related genetic variants predict toxicity following definitive radiotherapy for lung cancer. Clin Pharmacol Ther (2014) 0.77
ARF1-regulated coatomer directs the steady-state localization of protein kinase C epsilon at the Golgi apparatus. Biochim Biophys Acta (2012) 0.76
PKCε Is an Essential Mediator of Prostate Cancer Bone Metastasis. Mol Cancer Res (2015) 0.75
Protein kinase C in cancer: The top five unanswered questions. Mol Carcinog (2017) 0.75
Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A (2005) 167.46
EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science (2004) 61.56
EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib. Proc Natl Acad Sci U S A (2004) 33.85
Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci U S A (2001) 24.34
Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J (2000) 22.23
The selectivity of protein kinase inhibitors: a further update. Biochem J (2007) 15.73
Cell signaling by receptor tyrosine kinases. Cell (2010) 12.39
RAS oncogenes: the first 30 years. Nat Rev Cancer (2003) 8.61
The specificities of protein kinase inhibitors: an update. Biochem J (2003) 7.76
Quantitative measurement of sn-1,2-diacylglycerols present in platelets, hepatocytes, and ras- and sis-transformed normal rat kidney cells. J Biol Chem (1986) 5.78
Protein kinase C and other diacylglycerol effectors in cancer. Nat Rev Cancer (2007) 5.71
ras-transformed cells: altered levels of phosphatidylinositol-4,5-bisphosphate and catabolites. Science (1986) 3.08
Overexpression of protein kinase C-delta and -epsilon in NIH 3T3 cells induces opposite effects on growth, morphology, anchorage dependence, and tumorigenicity. J Biol Chem (1993) 2.62
Regulation of cell apoptosis by protein kinase c delta. Apoptosis (2003) 2.60
PKC at a glance. J Cell Sci (2004) 2.30
Molecular genetics of lung cancer. Annu Rev Med (2001) 2.25
Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung. Cancer Res (1993) 2.14
A selective epsilon-protein kinase C antagonist inhibits protection of cardiac myocytes from hypoxia-induced cell death. J Biol Chem (1997) 2.03
Signaling through protein kinase C. Front Biosci (1998) 1.78
Pharmacological inhibition of epsilon PKC suppresses chronic inflammation in murine cardiac transplantation model. J Mol Cell Cardiol (2007) 1.78
Transgenic overexpression of PKCε in the mouse prostate induces preneoplastic lesions. Cell Cycle (2011) 1.74
Cardioprotection by epsilon-protein kinase C activation from ischemia: continuous delivery and antiarrhythmic effect of an epsilon-protein kinase C-activating peptide. Circulation (2004) 1.60
Protein kinase Cepsilon makes the life and death decision. Cell Signal (2007) 1.57
Protein kinase C epsilon: an oncogene and emerging tumor biomarker. Mol Cancer (2009) 1.56
Protein kinase Cepsilon activates protein kinase B/Akt via DNA-PK to protect against tumor necrosis factor-alpha-induced cell death. J Biol Chem (2006) 1.44
Protein kinase C-mediated regulation of the cell cycle. Front Biosci (2000) 1.34
Protein kinase C-epsilon regulates the apoptosis and survival of glioma cells. Cancer Res (2005) 1.33
Protein kinase Cepsilon interacts with Bax and promotes survival of human prostate cancer cells. Oncogene (2003) 1.29
Protein kinase C-epsilon transgenic mice: a unique model for metastatic squamous cell carcinoma. Cancer Res (2001) 1.26
Biodistribution of intracellularly acting peptides conjugated reversibly to Tat. Biochem Biophys Res Commun (2004) 1.22
Protein kinase C inhibitors as novel anticancer drugs. Expert Opin Investig Drugs (2001) 1.18
Protein kinase C epsilon is overexpressed in primary human non-small cell lung cancers and functionally required for proliferation of non-small cell lung cancer cells in a p21/Cip1-dependent manner. Cancer Res (2007) 1.08
Preclinical and clinical development of novel agents that target the protein kinase C family. Semin Oncol (2006) 1.03
Cells that overproduce protein kinase C are more susceptible to transformation by an activated H-ras oncogene. Mol Cell Biol (1989) 1.03
S-Phase-specific activation of PKC alpha induces senescence in non-small cell lung cancer cells. J Biol Chem (2007) 1.02
Modulating protein kinase C signal transduction. Adv Pharmacol (1998) 1.01
Phorbol ester-induced G1 phase arrest selectively mediated by protein kinase Cdelta-dependent induction of p21. J Biol Chem (2005) 1.00
Overexpression of protein kinase C epsilon is oncogenic in rat colonic epithelial cells. Oncogene (1996) 1.00
Protein kinase C isozymes, novel phorbol ester receptors and cancer chemotherapy. Curr Pharm Des (2001) 0.99
Central role of protein kinase Cepsilon in constitutive activation of ERK1/2 and Rac1 in the malignant cells of hairy cell leukemia. Am J Pathol (2007) 0.97
Differential regulation of gene expression by protein kinase C isozymes as determined by genome-wide expression analysis. J Biol Chem (2011) 0.97
Hallmarks for senescence in carcinogenesis: novel signaling players. Apoptosis (2009) 0.95
Competitive inhibitors and allosteric activators of protein kinase C isoenzymes: a personal account and progress report on transferring academic discoveries to the clinic. Biochem Soc Trans (2007) 0.90
Inhibition of novel protein kinase C-epsilon augments TRAIL-induced cell death in A549 lung cancer cells. Pathol Oncol Res (2007) 0.87
c-myc gene-induced alterations in protein kinase C expression: a possible mechanism facilitating myc-ras gene complementation. Cancer Res (1991) 0.80
Altered expression of cyclins and c-fos in R6 cells that overproduce PKC epsilon. Carcinogenesis (1995) 0.80
Lipid signalling pathways in normal and ras-transfected NIH/3T3 cells. Cell Signal (1989) 0.76
Epigenetic memory in induced pluripotent stem cells. Nature (2010) 14.31
Coaxial stacking of helixes enhances binding of oligoribonucleotides and improves predictions of RNA folding. Proc Natl Acad Sci U S A (1994) 8.06
Real-time prediction of hand trajectory by ensembles of cortical neurons in primates. Nature (2000) 7.29
Selective inhibition of protein kinase C isozymes by the indolocarbazole Gö 6976. J Biol Chem (1993) 7.16
A novel family of divergent seven-transmembrane proteins: candidate odorant receptors in Drosophila. Neuron (1999) 6.03
Apg9p/Cvt7p is an integral membrane protein required for transport vesicle formation in the Cvt and autophagy pathways. J Cell Biol (2000) 4.30
Anti-VEGF antibody treatment of glioblastoma prolongs survival but results in increased vascular cooption. Neoplasia (2001) 4.22
The itinerary of a vesicle component, Aut7p/Cvt5p, terminates in the yeast vacuole via the autophagy/Cvt pathways. J Biol Chem (2000) 3.97
Cloning of an intracellular receptor for protein kinase C: a homolog of the beta subunit of G proteins. Proc Natl Acad Sci U S A (1994) 3.95
Identification of a novel bacterial sequence associated with Crohn's disease. Gastroenterology (2000) 3.90
Dissection of autophagosome biogenesis into distinct nucleation and expansion steps. J Cell Biol (2000) 3.64
Human chromosome 19 and related regions in mouse: conservative and lineage-specific evolution. Science (2001) 3.39
Opposing cardioprotective actions and parallel hypertrophic effects of delta PKC and epsilon PKC. Proc Natl Acad Sci U S A (2001) 3.28
Calmodulin target database. J Struct Funct Genomics (2000) 3.20
Protein kinase C isozymes and the regulation of diverse cell responses. Am J Physiol Lung Cell Mol Physiol (2000) 3.13
Cvt19 is a receptor for the cytoplasm-to-vacuole targeting pathway. Mol Cell (2001) 3.12
Repression by Ikaros and Aiolos is mediated through histone deacetylase complexes. EMBO J (1999) 3.11
Crystal structure of the cys2 activator-binding domain of protein kinase C delta in complex with phorbol ester. Cell (1995) 3.08
Survey of extended-spectrum beta-lactamases in clinical isolates of Escherichia coli and Klebsiella pneumoniae: prevalence of TEM-52 in Korea. J Clin Microbiol (1999) 3.04
Codon-improved Cre recombinase (iCre) expression in the mouse. Genesis (2002) 2.92
Bone-targeted therapy for advanced androgen-independent carcinoma of the prostate: a randomised phase II trial. Lancet (2001) 2.85
Soft tissue cephalometric analysis: diagnosis and treatment planning of dentofacial deformity. Am J Orthod Dentofacial Orthop (1999) 2.81
Uncovering of functional alternative CTLA-4 counter-receptor in B7-deficient mice. Science (1993) 2.78
Malignant tumours of the heart: a review of tumour type, diagnosis and therapy. Clin Oncol (R Coll Radiol) (2007) 2.67
Overexpression of protein kinase C-delta and -epsilon in NIH 3T3 cells induces opposite effects on growth, morphology, anchorage dependence, and tumorigenicity. J Biol Chem (1993) 2.62
Surface attachment of Salmonella typhimurium to intestinal epithelia imprints the subepithelial matrix with gradients chemotactic for neutrophils. J Cell Biol (1995) 2.53
Regional pattern of white matter microstructural changes in normal aging, MCI, and AD. Neurology (2009) 2.47
Measurement in vivo of proliferation rates of slow turnover cells by 2H2O labeling of the deoxyribose moiety of DNA. Proc Natl Acad Sci U S A (2002) 2.46
Sustained in vivo cardiac protection by a rationally designed peptide that causes epsilon protein kinase C translocation. Proc Natl Acad Sci U S A (1999) 2.44
New insights into the regulation of protein kinase C and novel phorbol ester receptors. FASEB J (1999) 2.39
Distinct functional phenotypes of cloned Ia-restricted helper T cells. J Exp Med (1985) 2.39
Design of biomimetic fibrillar interfaces: 1. Making contact. J R Soc Interface (2004) 2.38
Electron microscope studies of heteroduplex DNA from a deletion mutant of bacteriophage phiX-174. Proc Natl Acad Sci U S A (1972) 2.29
Immunosuppressive drugs prevent a rapid dephosphorylation of transcription factor NFAT1 in stimulated immune cells. Proc Natl Acad Sci U S A (1995) 2.24
Ultrabithorax regulates genes at several levels of the wing-patterning hierarchy to shape the development of the Drosophila haltere. Genes Dev (1998) 2.22
Mutations in the LKB1 tumour suppressor are frequently detected in tumours from Caucasian but not Asian lung cancer patients. Br J Cancer (2008) 2.21
A kinase-deficient transcription factor TFIIH is functional in basal and activated transcription. Proc Natl Acad Sci U S A (1995) 2.20
Chronic hypersensitivity for inflammatory nociceptor sensitization mediated by the epsilon isozyme of protein kinase C. J Neurosci (2000) 2.20
A protein kinase C translocation inhibitor as an isozyme-selective antagonist of cardiac function. J Biol Chem (1996) 2.16
Genetic ablation of parathyroid glands reveals another source of parathyroid hormone. Nature (2000) 2.13
Evolution of HIV-1 coreceptor usage through interactions with distinct CCR5 and CXCR4 domains. Proc Natl Acad Sci U S A (1997) 2.11
An association study of asthma and total serum immunoglobin E levels for Toll-like receptor polymorphisms in a Japanese population. Clin Exp Allergy (2004) 2.10
Unique and shared functions of different connexins in mice. Curr Biol (2000) 2.10
Expression of chemokine receptors by subsets of neurons in the central nervous system. J Immunol (1997) 2.10
Stroke mechanism in patients with non-valvular atrial fibrillation according to the CHADS2 and CHA2 DS2 -VASc scores. Eur J Neurol (2011) 2.09
Low prevalence of valvular heart disease in 226 phentermine-fenfluramine protocol subjects prospectively followed for up to 30 months. J Am Coll Cardiol (1999) 2.09
Effects of exercise during long-term support with a left ventricular assist device. Results of the experience with left ventricular assist device with exercise (EVADE) pilot trial. Circulation (1997) 2.06
Melasma: histopathological characteristics in 56 Korean patients. Br J Dermatol (2002) 2.05
A selective epsilon-protein kinase C antagonist inhibits protection of cardiac myocytes from hypoxia-induced cell death. J Biol Chem (1997) 2.03
Capacity of multidrug-resistant clinical isolates of Acinetobacter baumannii to form biofilm and adhere to epithelial cell surfaces. Clin Microbiol Infect (2007) 2.00
An outbreak of Campylobacter jejuni infections associated with food handler contamination: the use of pulsed-field gel electrophoresis. J Infect Dis (2000) 1.99
Apg2 is a novel protein required for the cytoplasm to vacuole targeting, autophagy, and pexophagy pathways. J Biol Chem (2001) 1.99
Adaptor proteins in protein kinase C-mediated signal transduction. Oncogene (2001) 1.99
The Vestigial and Scalloped proteins act together to directly regulate wing-specific gene expression in Drosophila. Genes Dev (1998) 1.99
Vascular and metabolic response to isolated small muscle mass exercise: effect of age. Am J Physiol Heart Circ Physiol (2003) 1.97
Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: a model of glioblastoma multiforme pathophysiology. Mol Biol Cell (1993) 1.97
Analysis of hepatitis C virus capsid, E1, and E2/NS1 proteins expressed in insect cells. Virology (1993) 1.92
Assembly of an A kinase-anchoring protein-beta(2)-adrenergic receptor complex facilitates receptor phosphorylation and signaling. Curr Biol (2000) 1.90
Localization of psoriasis-susceptibility locus PSORS1 to a 60-kb interval telomeric to HLA-C. Am J Hum Genet (2000) 1.86
Correlated errors in biased surrogates: study designs and methods for measurement error correction. Stat Med (2005) 1.85
The regulation of AMP-activated protein kinase by H(2)O(2). Biochem Biophys Res Commun (2001) 1.84
C2 region-derived peptides inhibit translocation and function of beta protein kinase C in vivo. J Biol Chem (1995) 1.82
Localization of protein kinase C isozymes in cardiac myocytes. Exp Cell Res (1994) 1.82
Localization of the Vpx packaging signal within the C terminus of the human immunodeficiency virus type 2 Gag precursor protein. J Virol (1994) 1.81
Murine B7-2, an alternative CTLA4 counter-receptor that costimulates T cell proliferation and interleukin 2 production. J Exp Med (1993) 1.81
Carbapenem resistance mechanisms in Pseudomonas aeruginosa clinical isolates. Antimicrob Agents Chemother (2001) 1.81
Mutational analysis of the hepatitis C virus RNA helicase. J Virol (1997) 1.77
Targeting foreign proteins to human immunodeficiency virus particles via fusion with Vpr and Vpx. J Virol (1995) 1.77
Visual and instrumental colorimetric assessments of small color differences on translucent dental porcelain. J Dent Res (1989) 1.77
The coatomer protein beta'-COP, a selective binding protein (RACK) for protein kinase Cepsilon. J Biol Chem (1997) 1.76
Degradation of lipid vesicles in the yeast vacuole requires function of Cvt17, a putative lipase. J Biol Chem (2000) 1.75
Intracellular transport and virion incorporation of vpx requires interaction with other virus type-specific components. Virology (1993) 1.75
Evidence of zeta protein kinase C involvement in polymorphonuclear neutrophil integrin-dependent adhesion and chemotaxis. J Biol Chem (1998) 1.74
The nitrogenase FeMo-cofactor and P-cluster pair: 2.2 A resolution structures. Science (1993) 1.74
Results of transvenous embolization of cavernous dural arteriovenous fistula: a single-center experience with emphasis on complications and management. AJNR Am J Neuroradiol (2006) 1.73
Electrical conduction through poly(dA)-poly(dT) and poly(dG)-poly(dC) DNA molecules. Phys Rev Lett (2001) 1.72
Evidence for autoregulation of cystathionine gamma-synthase mRNA stability in Arabidopsis. Science (1999) 1.72
Mania in children with pervasive developmental disorder revisited. J Am Acad Child Adolesc Psychiatry (1997) 1.68
Physician fees and procedure intensity: the case of cesarean delivery. J Health Econ (1999) 1.68
Multiple sets of basal factors initiate transcription by RNA polymerase II. J Biol Chem (1994) 1.68
Activation of NF-kappaB by the human herpesvirus 8 chemokine receptor ORF74: evidence for a paracrine model of Kaposi's sarcoma pathogenesis. J Virol (2001) 1.68
An autoregulatory region in protein kinase C: the pseudoanchoring site. Proc Natl Acad Sci U S A (1995) 1.67
Vascular and metabolic response to cycle exercise in sedentary humans: effect of age. Am J Physiol Heart Circ Physiol (2002) 1.67
Activation of the TFIID-TFIIA complex with HMG-2. Genes Dev (1995) 1.66
Structure and chromosomal location of the gene for endothelial-leukocyte adhesion molecule 1. J Biol Chem (1991) 1.66
Plasma levels of interleukin-6 and its soluble receptor are associated with prostate cancer progression and metastasis. Urology (2001) 1.65
Head taps evoke a crossed vestibulo-ocular reflex. Neurology (2007) 1.65
Domain structure and phosphorylation of protein kinase C. J Biol Chem (1987) 1.65
Neuroendocrine function and response to stress in mice with complete disruption of glucagon-like peptide-1 receptor signaling. Endocrinology (2000) 1.63
New proteins related to the Ser-Arg family of splicing factors. RNA (1995) 1.62
Peptide modulators of protein-protein interactions in intracellular signaling. Nat Biotechnol (1998) 1.62
Mutation in the gene responsible for cystic fibrosis and predisposition to chronic rhinosinusitis in the general population. JAMA (2000) 1.62
DNA bending by negative regulatory proteins: Gal and Lac repressors. Genes Dev (1989) 1.62
Assembly, specific binding, and crystallization of a human TCR-alphabeta with an antigenic Tax peptide from human T lymphotropic virus type 1 and the class I MHC molecule HLA-A2. J Immunol (1996) 1.59
Alpha 4-integrins mediate antigen-induced late bronchial responses and prolonged airway hyperresponsiveness in sheep. J Clin Invest (1994) 1.58
Molecular transporters for peptides: delivery of a cardioprotective epsilonPKC agonist peptide into cells and intact ischemic heart using a transport system, R(7). Chem Biol (2001) 1.58